keyboard_arrow_up

Market Estimates on Global Tissue Diagnostic, 2015-2020

Global Tissue Diagnostic Market Research And Analysis, 2015-2020 is a new market research publication announced by Reportstack. Global Tissue Diagnostic Market is expected to exceed $5 billion in 2020 with a CAGR 7.2% during 2015-2020. The rising incidence and prevalence rate of cancer gave rise to tissue diagnostic market. Cancer is a fetal disease and it is prevalent across the globe with huge economic burden in emerging and low-middle income group countries. It has considerable presence in developed and developing economies such as US, UK, Spain, China, India and Korea. Tissue diagnosis includes Hematoxylin & Eosin (H&E) Stain, Immunohistochemistry (IHC) Test, Fluorescent In Situ Hybridization (FISH) Test, Silver In Situ Hybridization (SISH) Test, Pathology and other stain tests. These diagnostic services are widely available and due to technological advancement, innovation and efficient results these diagnostic devices are in huge demand.

To access full report with TOC, please visit Global Tissue Diagnostic Market Research And Analysis, 2015-2020

Global tissue diagnostic market is expected to grow significantly due to rise in adoption of personalized healthcare, in-vitro diagnostic, incidence and prevalence rate of cancer. The results of research & development and critical FDA approvals on diagnostic devices enable the tissue diagnostic market to grow fast. Funding from government and private players are also key factors to drive the global tissue diagnostic market. However, high cost of tissue diagnostic and less awareness among emerging and low-middle income group countries are concern for the growth tissue diagnostic market.

Regional Insights:

North America generates highest revenues across the globe due to huge number of Cancer patients and highest rate of healthcare spending followed by Europe. Untapped APAC region such as China, India, Japan and Korea are the most emerging economies and expected to create huge opportunity for tissue diagnostic market. Improved healthcare spending, infrastructure and favorable government policies are the key factors which are expected to drive the APAC market. The report includes detailed Market Overview, Market Determinants, Company Profiling, Sector Analysis, Market Segmentation, Geographical Analysis, Pipeline Analysis, Strategic Recommendations, Key Company Analysis, GAP Analysis, Key Findings, Market Estimations, Market Insights, Analyst Insights and predictive analysis of the market.

The report also covers various factors that influence the market such as the government regulations, drug and device laws and regulations, regulations on clinical trials, government policies and so on are covered at length. The report also covers parametric analysis, historical analysis and tissue diagnosis which includes various test such as Hematoxylin and silver in situ hybridization test. Global tissue diagnostic market is segmented on the basis of technology, diagnosis, product, end user and geography. Global tissue diagnostic market by diagnosis and end user are expected to contribute significantly due to huge demand created by cancer patients.

Competitive Insights:

The key players of global tissue diagnostic market includes Abbott Laboratories, Roche Holdings AG, Biogenex Laboratories, Bio SB, Agilent Technologies Cell Signaling Technology, Danaher Corporation, Sigma-Aldrich, Thermo Fisher Scientific, Qiagen, Becton Dickinson & company, Alere, Diagenic, Stryker, Biomeriux, Promethius Laboratories, Life Technologies, GE healthcare, Philips, Siemens, Johnson & Johnson, Quest Diagnostic, Axxin, Caris Life Sciences, Singulux, Teco Diagnostic, Ribomed, Signal Genetics and so on.

Market Segmentation:

Global Tissue Diagnostic Market is segmented on the basis of technology, product, diagnosis, end user and region. Global tissue diagnostic market by technology and end user has significant contribution in generating huge revenues across the geographies. The global tissue diagnostic market by technology includes Immunohistochemistry, In Situ Hybridization, Digital Pathology and Workflow Management, Magnetoencephalograph and so on. The rising Cancer patients created huge demand for diagnostic technology and devices.

Companies Mentioned

1. ROCHE HOLDINGS AG 2. BIOGENEX LABORATORIES 3. BIO SB. 4. CELL SIGNALLING TECHNOLOGY, INC. 5. QIAGEN 6. BECTON DICKINSON & COMPANY 7. ALERE 8. DIAGENIC 9. STRYKER 10. BIOMERIUX 11. PROMETHEUS LABORATORIES 12. AGILENT TECHNOLOGIES 13. DANAHER CORPORATION. 14. LIFE TECHNOLOGIES 15. GE HEALTHCARE 16. PHILIPS 17. SIEMENS 18. JOHNSON & JOHNSON 19. QUEST DIAGNOSTIC 20. AXXIN 21. CARIS LIFE SCIENCES 22. SINGULEX 23. TECO DIAGNOSTICS 24. RIBOMED 25. SIGNAL GENETICS 26. TRINITY BIOTECH 27. NOVARTIS DIAGNOSTICS 28. NOVODIAX 29. BIOCEPT 30. EUROGENTEC

Contact:

Debora White

Manager - Marketing

Ph: +1-888-789-6604

Reportstack Market Research

###